The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.
The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, China.
Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1820-1828. doi: 10.1016/j.ejso.2020.06.015. Epub 2020 Jun 19.
Although multifocality is often observed in papillary thyroid carcinoma (PTC), the associations with clinicopathologic factors and the prognostic value are still controversial. We aimed to identify the risk factors for multifocality and bilaterality, and investigate the significance of multifocality on prognosis in all PTC, papillary thyroid microcarcinoma (PTMC) and non-PTMC.
Data from 635 patients who underwent lobectomy/total thyroidectomy plus cervical lymph node dissection for PTC were retrospectively analyzed. Clinicopathological factors associated with multifocal PTC and bilateral PTC were investigated by univariate analysis. Multivariate Cox regression analyses was used to identify the clinicopathological prognostic factors for recurrence-free survival.
Multifocal and bilateral PTC were observed in 157 (24.7%) and 99 (15.6%) patients, respectively. The frequency of large diameter (>1.0 cm), extrathyroidal extension (ETE), vascular invasion and central lymph node metastases (CLNM) was higher in multifocal PTC than that of solitary PTC. Moreover, ETE, vascular invasion, CLNM and lateral lymph node metastasis (LLNM) were more frequent in patients with 3 or more tumor foci compared to those with 2 tumor foci and 1 tumor lesion. Bilateral PTC had higher rates of ETE and CLNM. Multifocality was found to be the predictor of recurrence in all PTC, PTMC, and non-PTMC. In addition, the risk of recurrence increased with increasing number of tumor foci in all multifocal PTC patients and multifocal non-PTMC patients.
Although multifocality and bilaterality had more aggressive features in PTC, only multifocality was associated with the increased risk of recurrence. An increase in the number of tumors was associated with an increased risk of ETE, vascular invasion, CLNM and LLNM. The prognostic value of multifocality is particularly significant in non-PTMC patients.
虽然多灶性在甲状腺乳头状癌(PTC)中经常观察到,但与临床病理因素的关联及其预后价值仍存在争议。我们旨在确定多灶性和双侧性的危险因素,并研究所有 PTC、甲状腺微小乳头状癌(PTMC)和非-PTMC 中多灶性对预后的意义。
回顾性分析了 635 例接受甲状腺叶切除术/全甲状腺切除术加颈淋巴结清扫术治疗 PTC 的患者的数据。通过单因素分析研究与多灶性 PTC 和双侧 PTC 相关的临床病理因素。使用多因素 Cox 回归分析确定无复发生存的临床病理预后因素。
多灶性和双侧 PTC 分别在 157(24.7%)和 99(15.6%)例患者中观察到。多灶性 PTC 的大直径(>1.0cm)、甲状腺外延伸(ETE)、血管侵犯和中央淋巴结转移(CLNM)的频率高于单发 PTC。此外,与 2 个肿瘤病灶和 1 个肿瘤病灶相比,有 3 个或更多肿瘤病灶的患者 ETE、血管侵犯、CLNM 和侧淋巴结转移(LLNM)更为常见。双侧 PTC 的 ETE 和 CLNM 发生率更高。多灶性被发现是所有 PTC、PTMC 和非-PTMC 复发的预测因素。此外,所有多灶性 PTC 患者和多灶性非-PTMC 患者中,随着肿瘤病灶数量的增加,复发的风险也增加。
尽管 PTC 中的多灶性和双侧性具有更具侵袭性的特征,但只有多灶性与复发风险增加相关。肿瘤数量的增加与 ETE、血管侵犯、CLNM 和 LLNM 的风险增加相关。多灶性的预后价值在非-PTMC 患者中尤为显著。